A general NMR method for rapid, efficient, and reliable biochemical screening

被引:103
作者
Dalvit, C
Ardini, E
Flocco, M
Fogliatto, GP
Mongelli, N
Veronesi, M
机构
[1] Pharmacia, Dept Chem, I-20014 Nerviano, MI, Italy
[2] Pharmacia, Dept Biol, I-20014 Nerviano, MI, Italy
关键词
D O I
10.1021/ja038128e
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
High-throughput screening is usually the method of drug-lead discovery. It is now well accepted that, for a functional assay, quality is more important than quantity. The ligand-based or protein-based NMR screening methodologies for detecting compounds binding to the macromolecular target of interest are now well established. A novel and sensitive NMR method for rapid, efficient, and reliable biochemical screening is presented. The method named 3-FABS (three fluorine atoms for biochemical screening) requires the labeling of the substrate with a CF3 moiety and utilizes F-19 NMR spectroscopy for the detection of the starting and enzymatically modified substrates. The method allows for high-quality screening of large compound or natural product extract collections and for measuring their IC50 values. Applications of this technique to the screening of inhibitors of the Ser/Thr kinase AKT1 and the protease trypsin are presented. In addition, an interesting application of 3-FABS to functional genomics is also presented.
引用
收藏
页码:14620 / 14625
页数:6
相关论文
共 34 条
[21]   NMR screening in drug discovery [J].
Moore, JM .
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (01) :54-58
[22]   Peptide and protein library screening defines optimal substrate motifs for AKT/PKB [J].
Obata, T ;
Yaffe, MB ;
Leparc, GG ;
Piro, ET ;
Maegawa, H ;
Kashiwagi, A ;
Kikkawa, R ;
Cantley, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :36108-36115
[23]   NMR in drug discovery [J].
Pellecchia, M ;
Sem, DS ;
Wüthrich, K .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) :211-219
[24]  
Peng JW, 2001, METHOD ENZYMOL, V338, P202
[25]   F-19 NMR INVESTIGATIONS OF THE CATALYTIC MECHANISM OF PHOSPHOGLUCOMUTASE USING FLUORINATED SUBSTRATES AND INHIBITORS [J].
PERCIVAL, MD ;
WITHERS, SG .
BIOCHEMISTRY, 1992, 31 (02) :505-512
[26]   Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice [J].
Pope, AJ ;
Haupts, UM ;
Moore, KJ .
DRUG DISCOVERY TODAY, 1999, 4 (08) :350-362
[27]  
Price N. C., 1999, FUNDAMENTALS ENZYMOL
[28]   Toward a PKB inhibitor: Modification of a selective PKA inhibitor by rational design [J].
Reuveni, H ;
Livnah, N ;
Geiger, T ;
Kleid, S ;
Ohne, O ;
Cohen, I ;
Benhar, M ;
Gellerman, G ;
Levitzki, A .
BIOCHEMISTRY, 2002, 41 (32) :10304-10314
[29]  
Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453b
[30]   THYMIC LYMPHOMA INDUCTION BY THE AKT8-MURINE RETROVIRUS [J].
STAAL, SP ;
HARTLEY, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (03) :1259-1264